Advocacy intelligence hub — real-time data for patient organizations
Calcilytix Therapeutics, Inc., a BridgeBio company — PHASE2, PHASE3
Calcilytix Therapeutics, Inc., a BridgeBio company — PHASE3
Calcilytix Therapeutics, Inc., a BridgeBio company
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Calcilytix Medical Director
Calcilytix Therapeutics, Inc., a BridgeBio company
Saleh K Saleh, MD
Minia University
📍 Minya, Minya Governorate
Anne Blanchard, MD, PhD
Assistance Publique - Hôpitaux de Paris
Agnes Linglart, MD, PhD
Assistance Publique - Hôpitaux de Paris
Karen K Winer, M.D., PT
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
📍 MILWAUKIE, OR
Lars Rejnmark, DmSci, PhD
Aarhus University Hospital